Dr. Thomas B. “Brad” Gold
has been appointed vice president of pharmaceutical development at Metrics, Inc.
The promotion expands Dr. Gold’s previous role as senior director of pharmaceutical development and new technology. He will manage formulation development, potent and cytotoxic products, fast-track development, analytical methods development and validation. Mr. Gold will also be responsible for implementing new technology platforms that include advanced drug delivery methods.
“After demonstrating solid leadership here at Metrics for more than 10 years, Brad has more than earned the trust and respect of our entire team,” said Phil Hodges, Metrics’ president. “He has the scientific knowledge and operational management skills we need to continue growing our core pharmaceutical development capabilities.”